- Home
- CMRX vs RFMZ Comparison
CMRX vs RFMZ Comparison
Compare CMRX & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- RFMZ
- Stock Information
- Founded
- CMRX 2000
- RFMZ 2021
- Country
- CMRX United States
- RFMZ United States
- Employees
- CMRX N/A
- RFMZ N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- RFMZ Trusts Except Educational Religious and Charitable
- Sector
- CMRX Health Care
- RFMZ Finance
- Exchange
- CMRX Nasdaq
- RFMZ Nasdaq
- Market Cap
- CMRX 394.1M
- RFMZ 346.8M
- IPO Year
- CMRX 2013
- RFMZ N/A
- Fundamental
- Price
- CMRX $8.51
- RFMZ $13.42
- Analyst Decision
- CMRX Hold
- RFMZ
- Analyst Count
- CMRX 4
- RFMZ 0
- Target Price
- CMRX $8.51
- RFMZ N/A
- AVG Volume (30 Days)
- CMRX 8.5M
- RFMZ 76.6K
- Earning Date
- CMRX 03-21-2025
- RFMZ 01-01-0001
- Dividend Yield
- CMRX N/A
- RFMZ 7.43%
- EPS Growth
- CMRX N/A
- RFMZ N/A
- EPS
- CMRX N/A
- RFMZ 0.65
- Revenue
- CMRX $212,000.00
- RFMZ N/A
- Revenue This Year
- CMRX $2,685.38
- RFMZ N/A
- Revenue Next Year
- CMRX $1,050.23
- RFMZ N/A
- P/E Ratio
- CMRX N/A
- RFMZ $21.49
- Revenue Growth
- CMRX N/A
- RFMZ N/A
- 52 Week Low
- CMRX $0.75
- RFMZ $11.28
- 52 Week High
- CMRX $8.53
- RFMZ $14.57
- Technical
- Relative Strength Index (RSI)
- CMRX 83.55
- RFMZ 35.13
- Support Level
- CMRX $8.41
- RFMZ $13.37
- Resistance Level
- CMRX $8.52
- RFMZ $13.66
- Average True Range (ATR)
- CMRX 0.02
- RFMZ 0.14
- MACD
- CMRX -0.14
- RFMZ -0.00
- Stochastic Oscillator
- CMRX 72.22
- RFMZ 16.35
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.